Iowa’s U.S. Senators Meet With HHS Top Brass About Pharma’s 340B Moves

Iowa’s U.S. Senators Meet With HHS Top Brass About Pharma’s 340B Moves

Both of Iowa’s U.S. senators met yesterday with “top officials” at the U.S. Health and

Read More »

U.S. House Democrats and Republicans “Deeply Concerned” About 340B Rebate Model

U.S. House Democrats and Republicans “Deeply Concerned” About 340B Rebate Model

Update, Thursday Oct. 22, 2020, 2:45 p.m. EDT—Kalderos provided us with the following updated comment regarding members of Congress’ concerns about its 340B Pay platform to enable drug manufacturers

Read More »

Breaking News

BREAKING: Health Centers Sue HHS Over Drug Company Denials of 340B Pricing

Health Centers Sue HHS Over Drug Company Denials of 340B Pricing

This is a developing story. Check the online version for possible updates.

The National Association of

Read More »

340B Hospitals Ponder Next Moves After U.S. Appeals Court Setback

A note from Publisher and CEO Ted Slafsky: I encourage you to read 340B Hudson Headwaters 340B President Jim Donnelly’s sponsored content article in today issue, on the challenges 340B stakeholders have faced over the last several months, and how

Read More »

Breaking News

BREAKING: Major Developments in 340B Hospital Lawsuit and in 340B Contract Pharmacy Dispute

U.S. Appeals Court Won’t Rehear Lawsuit Over Medicare Payment Cuts for Hospitals’ 340B-Purchased Drugs

The full U.S. Court of Appeals for the District of Columbia Circuit late this afternoon denied a motion to reconsider a three-judge panel’s July 31

Read More »

HIV/AIDS Activists March To Protest AstraZeneca’s 340B Contract Pharmacy Cutbacks

HIV/AIDS Activists March To Protest AstraZeneca’s 340B Contract Pharmacy Cutbacks

Activists aligned with the powerful grassroots group AIDS Healthcare Foundation (AHF) marched yesterday in front of drug manufacturer AstraZeneca’s Wilmington, Del., headquarters building to protest the company’s decision effective Oct.

Read More »

Sanofi Reportedly Is Not Providing Some Promised 340B Pricing

Sanofi Reportedly Is Not Providing Some Promised 340B Pricing

Some 340B covered entities report being unable to buy Sanofi covered outpatient drugs for their own pharmacies at discounted 340B prices in recent days, despite Sanofi’s assurances that its new limits

Read More »

Breaking News

BREAKING: HIV/AIDS Clinics Sue HHS Over Drug Manufacturers’ Denials of 340B Pricing

HIV/AIDS Clinics Sue HHS Over Drug Manufacturers’ Denials of 340B Pricing

(UPDATE Saturday Oct. 10, 2020, 9:20 a.m. EDT—The U.S. Health and Human Services Department (HHS) said

Read More »

Breaking News

BREAKING: Congressional GOP Committee Leaders Seek 340B Reform Ideas by Oct. 30

Congressional GOP Committee Leaders Seek 340B Reform Ideas by Oct. 30

The Republican chairman of the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee and the

Read More »

More than Half of Health Care Industry Execs Expect 340B Reporting Requirements Within Five Years

A message from 340B Report Publisher and CEO Ted Slafsky: We are pleased to have a sponsored content article today from Michael Gonzalez, President and Lead Consultant, FQHC340B, a valued 340B Report sponsor. I encourage you to read it. We will

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report